JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
1755 results found
Shareholders' meeting
Shareholders' Meeting September 4, 2024 - Summary report on votes
04/09/24 - 14:00
About Diasorin
Events
Shareholders%u2019 Meeting, Annual Report 2008 approval - First call
Newsroom
Events
Shareholders%u2019 Meeting, Annual Report 2008 approval - Second call
Newsroom
Molecular diagnostics Kits & reagents
Simplexa™ C. difficile Direct Kit
Molecular Diagnostics
Molecular diagnostics Kits & reagents
Simplexa™ C. difficile Universal Direct Kit
Molecular Diagnostics
Molecular diagnostics Kits & reagents
Simplexa™ Congenital CMV Direct Kit
Molecular Diagnostics
Molecular diagnostics Kits & reagents
Simplexa™ COVID-19 & Flu A/B Direct
Molecular Diagnostics
Molecular diagnostics Kits & reagents
Simplexa™ Flu A/B & RSV Direct Gen II
Molecular Diagnostics
Molecular diagnostics Kits & reagents
Simplexa™ Group A Strep Direct Kit
Molecular Diagnostics
Molecular diagnostics Kits & reagents
Simplexa™ Influenza A H5N1 Direct
Molecular Diagnostics
Press releases
Start up of the treasury shares buy-back plan
30/07/21 - 18:43
Investors
Press releases
Start up of the treasury shares buy-back plan
17/06/20 - 16:09
Investors
Buy back program
Start up of the treasury shares buy-back plan
06/04/21 - 14:00
About Diasorin
Buy back program
Start up of the treasury shares buy-back plan
30/07/21 - 14:00
About Diasorin
Press releases
Start up treasury shares buy-back plan
04/04/18 - 20:00
Investors
Press releases
Start up treasury shares buy-back plan
03/05/18 - 20:15
Investors
Press releases
Start up treasury shares buy-back plan
12/05/16 - 2:00
Investors
Events
Statutory Financial Statements 2012 approval and election of corporate bodies - First call
Newsroom
Events
Statutory Financial Statements 2012 approval and election of corporate bodies - Second call
Newsroom
Press releases
Stock options exercised by key managers
16/09/10 - 2:00
Investors
Press releases
Strong growth in revenues and cash flow generation in Q1 2022 - Full Year 2022 Guidance revised upwards
Price sensitive06/05/22 - 16:45
Investors
Press releases
Strong revenues growth in the First Half of 2022 - Full Year 2022 Guidance on both Revenues and Profitability revised upwards
Price sensitive03/08/22 - 12:26
Investors
Shareholders' meeting
Subscription form option and pre-emption offer for holders of the convertible bond
31/03/25 - 14:00
About Diasorin
Shareholders' meeting
Subscription form option and pre-emption offer for shareholders
31/03/25 - 14:00
About Diasorin
Press releases
Succession in the role of Group Chief Financial Officer of Diasorin. Alberto Donati appointed new Group Chief Financial Officer.
Price sensitive23/01/26 - 17:49
Investors
Shareholders' meeting
Summary report of the votes Shareholders' Meeting April 27, 2017
27/04/17 - 14:00
About Diasorin
Shareholders' meeting
Summary report of the votes upon the items of the agenda
22/04/15 - 14:00
About Diasorin
Shareholders' meeting
Summary report of the votes upon the items of the agenda
22/04/15 - 14:00
About Diasorin
Press releases
Suspension of the effectiveness of the disqualifying accessory administrative sanction imposed by CONSOB to the Chief Executive Officer Mr. Carlo Rosa
Price sensitive03/07/23 - 11:48
Investors
Shareholder basis
T. Rowe Price Associates, INC.
About Diasorin
Presentation
Test the future - Investor Day
11/06/19
Investors
Press releases
The Board of Directors approved to submit to the Shareholders' Meeting the authorization for the purchase and cancellation of treasury shares for the purpose of shareholder remuneration. Ordinary and extraordinary shareholders' meeting convened.
Price sensitive22/12/25 - 14:36
Investors
Press releases
The Board of Directors approves results for H1'16
04/08/16 - 2:00
Investors
Press releases
The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day
22/04/15 - 2:00
Investors
Press releases
The Board of Directors approves the Q3'13 Results
08/11/13 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'13
06/03/14 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'14
03/03/15 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'15
09/03/16 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'16
08/03/17 - 15:30
Investors
Press releases
The Board of Directors approves the results for H1'14
01/08/14 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'13
10/05/13 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'14
09/05/14 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'15
12/05/15 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'16
09/05/16 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q3'14
14/11/14 - 1:00
Investors
Press releases
The Board of Directors approves the results for Q3'15
11/11/15 - 1:00
Investors
Press releases
The Board of Directors approves the results for the first half of 2018
02/08/18 - 12:45
Investors
Press releases
The Board of Directors approves the results for the FY '12
30/01/13 - 1:00
Investors
Press releases
The Board of Directors approves the results for the H1 '13
01/08/13 - 2:00
Investors
Results
The Board of Directors of Diasorin SpA approves FY2023 Results; proposed ordinary dividend of € 1.15 per share
Investors
Press releases
The Board of Directors of Diasorin SpA approves FY2023 Results; proposed ordinary dividend of € 1.15 per share
Price sensitive15/03/24 - 13:35
Investors
Press releases
The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share
Price sensitive14/03/25 - 16:29
Investors
Press releases
The DiaSorin Group reports growth in revenues and profitability in the first quarter 2018
08/05/18 - 14:30
Investors
Press releases
The Extraordinary Meeting of Shareholders approves the enhancement of the increased voting rights mechanism
28/02/25 - 11:49
Investors
Press releases
The Extraordinary Shareholders' Meeting of DiaSorin authorizes the convertibility of the equity-linked bond and the share capital increase
04/10/21 - 12:27
Investors
Press releases
The LIAISON® SARS-COV-2 S1S2 IgG test is the first to receive the approval from Health Canada
18/05/20 - 11:28
Investors
Press releases
The LIAISON® SARS-COV-2 S1/S2 IgG test received the approval for the commercialization in Brazil from ANVISA
03/06/20 - 14:16
Investors
Press releases
The Ordinary Shareholders' meeting approves the 2010 statutory financial statements and the dividend distribution
28/04/11 - 2:00
Investors
Events
"The Right Test At The Right Time" Diasorin Molecular Diagnostics Day [In-Person Event]
Chicago
Newsroom
Press releases
The Shareholders' meeting authorized the purchase of treasury shares, approved the amendment of art. 5 of the articles of association and authorized the cancellation of treasury shares. The Board approved the launch of the buyback plan.
27/01/26 - 16:05
Investors
Press releases
The Shareholders’ meeting of Luminex Corporation approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin
21/06/21 - 18:49
Investors
Press releases
The Sonic Healthcare Group chooses DiaSorin
17/01/11 - 1:00
Investors
Press releases
Third Quarter results confirm guidance for Fiscal Year 2023
Price sensitive03/11/23 - 15:51
Investors
Coverage
UBS
Investors
Press releases
Update 2022 Annual Calendar of Corporate Events
06/05/22 - 17:33
Investors
Press releases
Update 2023 Annual Calendar of Corporate Events
27/07/23 - 14:27
Investors
Press releases
Update 2023 Annual Calendar of Corporate Events
07/02/23 - 12:01
Investors
Press releases
Update 2023 Annual Calendar of Corporate Events
27/03/23 - 15:52
Investors
Press releases
Update Annual Calendar of Corporate Events 2019
30/04/19 - 12:28
Investors
Press releases
Update Annual Calendar of Corporate Events 2020
16/09/20 - 14:30
Investors
Press releases
Update Annual Calendar of Corporate Events 2020
26/03/20 - 18:14
Investors
Press releases
Update annual calendar of corporate events 2022
08/04/22 - 9:53
Investors
Events
Update to the 2022 Annual Calendar of Corporate Events
Newsroom
Corporate Events Calendar
Updated Corporate Events Calendar (March 20, 2026)
20/03/26 - 13:00
About Diasorin
Events
Updated Timing - Invitation to Diasorin's Q2 2025 Results Conference Call
Newsroom
Molecular diagnostics Kits & reagents
VERIGENE® Clostridium difficile Test
Molecular Diagnostics
Molecular diagnostics Kits & reagents
VERIGENE® Enteric Pathogens Test
Molecular Diagnostics
Molecular diagnostics Kits & reagents
VERIGENE® Gram-Negative Blood Culture Test
Molecular Diagnostics
Molecular diagnostics Kits & reagents
VERIGENE® Gram-Positive Blood Culture Test
Molecular Diagnostics
Molecular diagnostics Kits & reagents
VERIGENE® Respiratory Pathogens Flex Test
Molecular Diagnostics
Press releases
Voluntarily removal from the STAR segment
11/07/11 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
03/06/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
10/06/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
06/04/18 - 19:45
Investors
Press releases
Weekly report treasury shares buy-back
13/04/18 - 20:30
Investors
Press releases
Weekly report treasury shares buy-back
19/04/18 - 21:00
Investors
Press releases
Weekly report treasury shares buy-back
11/05/18 - 20:15
Investors
Press releases
Weekly report treasury shares buy-back
20/05/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
27/05/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
19/05/18 - 1:45
Investors
Press releases
Weekly report treasury shares buy-back
25/05/18 - 22:30
Investors
Press releases
Weekly report treasury shares buy-back
01/06/18 - 20:15
Investors
Press releases
Weekly report treasury shares buy-back
08/06/18 - 23:15
Investors
Press releases
Weekly report treasury shares buy-back
15/06/18 - 21:00
Investors
Press releases
Weekly report treasury shares buy-back
22/06/18 - 20:30
Investors
Press releases
Weekly report treasury shares buy-back
29/06/18 - 18:15
Investors
Molecular diagnostics Kits & reagents
xTAG® Gastrointestinal Pathogen Panel (GPP)
Molecular Diagnostics
Pagination
- First page
- 1
- 2
- 3
- 4